| Abvi-goodwill | |
|
422 Clinton Ave S, Rochester, NY 14620-1103 | |
| (585) 232-1111 | |
| (585) 232-2972 |
| Full Name | Abvi-goodwill |
|---|---|
| Type | Facility |
| Speciality | Eyewear Supplier |
| Location | 422 Clinton Ave S, Rochester, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053397273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Secondary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Secondary |
| 332H00000X | Eyewear Supplier | (* (Not Available)) | Primary |
| Provider Name | Kevin B Wynne |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1598752784 PECOS PAC ID: 6608773239 Enrollment ID: I20031212000733 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Provider Name | Paul J Caito |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1699737965 PECOS PAC ID: 7416924220 Enrollment ID: I20040913000226 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Provider Name | Katherine G White |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184651754 PECOS PAC ID: 4385611144 Enrollment ID: I20040913000550 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Provider Name | Allison M Ford |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1437254331 PECOS PAC ID: 2860542958 Enrollment ID: I20090611000295 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Provider Name | Melanie A Shearer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831328897 PECOS PAC ID: 9032263629 Enrollment ID: I20090817000442 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Provider Name | Kimberly R Rosati |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609126994 PECOS PAC ID: 5890929848 Enrollment ID: I20131008000075 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Provider Name | Marycarol Graby |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1972944668 PECOS PAC ID: 4880812098 Enrollment ID: I20140902000130 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Provider Name | Jennifer L Krech |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275066144 PECOS PAC ID: 8123372141 Enrollment ID: I20181109002428 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abvi-goodwill 422 Clinton Ave S, Rochester, NY 14620-1103 Ph: (585) 232-1111 | Abvi-goodwill 422 Clinton Ave S, Rochester, NY 14620-1103 Ph: (585) 232-1111 |
News Archive
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells.
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
› Verified 3 days ago